申请人:Hoffmann-La Roche Inc.
公开号:US06353111B1
公开(公告)日:2002-03-05
2,3-Di-substituted trans olefinic N-heteroaromatic or urido propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a cycloalkyl ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
具有2,3-二取代的反式烯烃性N-杂环芳基或尿嘧啶丙酰胺,其中2-位取代为取代苯基,3-位取代为环烷基环,这些丙酰胺是葡萄糖激酶激活剂,可以增加胰岛素分泌,用于治疗2型糖尿病。